Builders Stage agenda revealed for Disrupt 2026

The Builders Stage is returning to TechCrunch Disrupt 2026, bringing together founders, startup operators, and investors for practical conversations on what it takes to build and scale successful companies. Hear from startup and venture leaders shaping the tech ecosystem, including Grant Lee, CEO and co-founder of Gamma; Leah Solivan, founder and general partner at Precedent.vc; Robby Stein, VP of…

Read More
Colossal Biosciences reportedly in talks to raise new capital at B–B valuation

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

When de-extinction startup Colossal Biosciences revealed last year that it was attempting to “resurrect” the dire wolf from genetic material found in fossils, we argued that, despite the controversy surrounding the project, the company was building valuable technologies that justify its $10.2 billion valuation. Now, roughly 16 months later, the startup is in talks to…

Read More
Builders Stage agenda revealed for Disrupt 2026

Builders Stage agenda revealed for Disrupt 2026

The Builders Stage is returning to TechCrunch Disrupt 2026, bringing together founders, startup operators, and investors for practical conversations on what it takes to build and scale successful companies. Hear from startup and venture leaders shaping the tech ecosystem, including Grant Lee, CEO and co-founder of Gamma; Leah Solivan, founder and general partner at Precedent.vc; Robby Stein, VP of…

Read More